Beryl Capital Management LLC 13D and 13G filings for Agile Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-13 1:21 pm Sale | 2024-09-30 | 13G | Agile Therapeutics, Inc. AGRX | Beryl Capital Management LLC | 0 0.000% | -680,000 (Position Closed) | Filing |
2024-07-09 2:20 pm Purchase | 2024-06-26 | 13G | Agile Therapeutics, Inc. AGRX | Beryl Capital Management LLC | 680,000 9.900% | 680,000 (New Position) | Filing |
2024-07-08 4:55 pm Purchase | 2024-06-26 | 13G | Agile Therapeutics, Inc. AGRX | Beryl Capital Management LLC | 680,000 9.900% | 680,000 (New Position) | Filing |